Cargando…
Blocking Ca(2+) Channel β(3) Subunit Reverses Diabetes
Voltage-gated Ca(2+) channels (Ca(v)) are essential for pancreatic beta cell function as they mediate Ca(2+) influx, which leads to insulin exocytosis. The β3 subunit of Ca(v) (Ca(v)β(3)) has been suggested to regulate cytosolic Ca(2+) ([Ca(2+)](i)) oscillation frequency and insulin secretion under...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6083041/ https://www.ncbi.nlm.nih.gov/pubmed/30044988 http://dx.doi.org/10.1016/j.celrep.2018.06.086 |
_version_ | 1783345901829357568 |
---|---|
author | Lee, Kayoung Kim, Jaeyoon Köhler, Martin Yu, Jia Shi, Yue Yang, Shao-Nian Ryu, Sung Ho Berggren, Per-Olof |
author_facet | Lee, Kayoung Kim, Jaeyoon Köhler, Martin Yu, Jia Shi, Yue Yang, Shao-Nian Ryu, Sung Ho Berggren, Per-Olof |
author_sort | Lee, Kayoung |
collection | PubMed |
description | Voltage-gated Ca(2+) channels (Ca(v)) are essential for pancreatic beta cell function as they mediate Ca(2+) influx, which leads to insulin exocytosis. The β3 subunit of Ca(v) (Ca(v)β(3)) has been suggested to regulate cytosolic Ca(2+) ([Ca(2+)](i)) oscillation frequency and insulin secretion under physiological conditions, but its role in diabetes is unclear. Here, we report that islets from diabetic mice show Ca(v)β(3) overexpression, altered [Ca(2+)](i) dynamics, and impaired insulin secretion upon glucose stimulation. Consequently, in high-fat diet (HFD)-induced diabetes, Ca(v)β(3)-deficient (Ca(v)β(3)(−/−)) mice showed improved islet function and enhanced glucose tolerance. Normalization of Ca(v)β(3) expression in ob/ob islets by an antisense oligonucleotide rescued the altered [Ca(2+)](i) dynamics and impaired insulin secretion. Importantly, transplantation of Ca(v)β(3)(−/−) islets into the anterior chamber of the eye improved glucose tolerance in HFD-fed mice. Ca(v)β(3) overexpression in human islets also impaired insulin secretion. We thus suggest that Ca(v)β(3) may serve as a druggable target for diabetes treatment. |
format | Online Article Text |
id | pubmed-6083041 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Cell Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-60830412018-08-10 Blocking Ca(2+) Channel β(3) Subunit Reverses Diabetes Lee, Kayoung Kim, Jaeyoon Köhler, Martin Yu, Jia Shi, Yue Yang, Shao-Nian Ryu, Sung Ho Berggren, Per-Olof Cell Rep Article Voltage-gated Ca(2+) channels (Ca(v)) are essential for pancreatic beta cell function as they mediate Ca(2+) influx, which leads to insulin exocytosis. The β3 subunit of Ca(v) (Ca(v)β(3)) has been suggested to regulate cytosolic Ca(2+) ([Ca(2+)](i)) oscillation frequency and insulin secretion under physiological conditions, but its role in diabetes is unclear. Here, we report that islets from diabetic mice show Ca(v)β(3) overexpression, altered [Ca(2+)](i) dynamics, and impaired insulin secretion upon glucose stimulation. Consequently, in high-fat diet (HFD)-induced diabetes, Ca(v)β(3)-deficient (Ca(v)β(3)(−/−)) mice showed improved islet function and enhanced glucose tolerance. Normalization of Ca(v)β(3) expression in ob/ob islets by an antisense oligonucleotide rescued the altered [Ca(2+)](i) dynamics and impaired insulin secretion. Importantly, transplantation of Ca(v)β(3)(−/−) islets into the anterior chamber of the eye improved glucose tolerance in HFD-fed mice. Ca(v)β(3) overexpression in human islets also impaired insulin secretion. We thus suggest that Ca(v)β(3) may serve as a druggable target for diabetes treatment. Cell Press 2018-07-24 /pmc/articles/PMC6083041/ /pubmed/30044988 http://dx.doi.org/10.1016/j.celrep.2018.06.086 Text en © 2018 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Lee, Kayoung Kim, Jaeyoon Köhler, Martin Yu, Jia Shi, Yue Yang, Shao-Nian Ryu, Sung Ho Berggren, Per-Olof Blocking Ca(2+) Channel β(3) Subunit Reverses Diabetes |
title | Blocking Ca(2+) Channel β(3) Subunit Reverses Diabetes |
title_full | Blocking Ca(2+) Channel β(3) Subunit Reverses Diabetes |
title_fullStr | Blocking Ca(2+) Channel β(3) Subunit Reverses Diabetes |
title_full_unstemmed | Blocking Ca(2+) Channel β(3) Subunit Reverses Diabetes |
title_short | Blocking Ca(2+) Channel β(3) Subunit Reverses Diabetes |
title_sort | blocking ca(2+) channel β(3) subunit reverses diabetes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6083041/ https://www.ncbi.nlm.nih.gov/pubmed/30044988 http://dx.doi.org/10.1016/j.celrep.2018.06.086 |
work_keys_str_mv | AT leekayoung blockingca2channelb3subunitreversesdiabetes AT kimjaeyoon blockingca2channelb3subunitreversesdiabetes AT kohlermartin blockingca2channelb3subunitreversesdiabetes AT yujia blockingca2channelb3subunitreversesdiabetes AT shiyue blockingca2channelb3subunitreversesdiabetes AT yangshaonian blockingca2channelb3subunitreversesdiabetes AT ryusungho blockingca2channelb3subunitreversesdiabetes AT berggrenperolof blockingca2channelb3subunitreversesdiabetes |